Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-19 of 19 for your search:
Drug:
7-hydroxystaurosporine
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of UCN-01 and Fludarabine in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
PMH-PHL-006
, NCI-5538, NCT00045513, 5538
2.
Phase II Study of UCN-01 in Patients With Unresectable Advanced or Metastatic Renal Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UCSF-NCI-5522
, NCI-5522, NCT00030888, 5522
3.
Phase II Study of UCN-01 and Fluorouracil in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-02049
, NCI-5509, 5509, NCT00045747
4.
Phase II Study of UCN-01 in Patients With Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CCC-PHII-33
, UCD-200311478-01, CHNMC-PHII-33, NCI-5536, NCT00072189, 5536
5.
Phase II Study of UCN-01 and Topotecan in Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
PMH-PHL-019
, NCI-6402, NCT00072267, 6402
6.
Phase II Study of UCN-01 and Topotecan in Patients With Small Cell Lung Cancer That Relapsed or Progressed After Prior First-Line Platinum-Based Chemotherapy
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
PMH-PHL-032
, NCI-6992, 6992, NCT00098956
7.
Phase I Study of Continuous-Infusion UCN-01 (a Staurosporine Analogue) in Patients With Refractory Solid Tumors or Lymphoma
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
NCI-95-C-0171N
, NCI-T95-0052N, T95-0052
8.
Phase I Study of UCN-01 in Patients with Advanced Solid Tumors or Chronic Lymphoproliferative Disorders (Summary Last Modified 09/2001)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-98012305
, NCI-T97-0083, NCT00003289
9.
Phase I Study of UCN-01 and Fludarabine in Patients With Recurrent or Refractory Low-Grade or Indolent Lymphoid Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-99-C-0127
, NCI-T99-0022, T99-0022, NCT00019838
10.
Phase I Study of Fluorouracil With UCN-01 in Patients With Advanced or Refractory Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-9924
, NCI-T99-0037, NCT00004059, T99-0037
11.
Phase I Study of UCN-01 and Cytarabine in Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome (Summary Last Modified 09/2000)
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
MDA-DM-99165
, NCI-T99-0100, NCT00004263, T99-0100
12.
Phase I Study of UCN-01 and Cisplatin in Patients With Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CHNMC-PHI-28
, NCI-T99-0065, NCT00006464, T99-0065
13.
Phase I Study of UCN-01 and Cisplatin in Patients With Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DMS-9934
, NCI-2331, NCT00012194, 2331
14.
Phase I Study of UCN-01 and Carboplatin in Patients With Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSGCC-0143
, NCI-5533, NCT00036777, 5533
15.
Phase I Study of UCN-01 and Gemcitabine in Patients With Unresectable or Metastatic Adenocarcinoma of the Pancreas
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MDA-DM-01553
, NCI-5510, NCT00039403, 5510
16.
Phase I Study of UCN-01, Fluorouracil, and Leucovorin Calcium in Patients With Metastatic or Unresectable Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-NAVY-01-04
, NCI-5535, NCI-02-C-0222, 5535, NCT00042861
17.
Phase I Study of UCN-01 and Prednisone in Patients With Refractory Solid Tumors or Lymphomas
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-02-C-0241
, NCI-5694, 5694, NCT00045500
18.
Phase I Study of UCN-01 and Topotecan in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
PMH-PHL-005
, NCI-5518, NCT00045175, 5518
19.
Phase I Study of UCN-01 and Irinotecan in Patients With Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J0173
, NCI-5528, NCT00047242, 5528
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
